T
Tosk
Tosk | Biopharmaceutical Company, Mountain View, California
About Tosk
Tosk Inc. is a biopharmaceutical company focused on improving outcomes for cancer patients. The company develops new drugs aimed at enhancing the safety and efficacy of existing cancer therapies while blocking the activity of cancer genes. Tosk's proprietary methods are designed to selectively prevent the adverse side effects of current treatments without compromising their effectiveness. Tosk serves the oncology market, targeting patients undergoing cancer treatments who are affected by the side effects of these therapies. The company's business model revolves around drug discovery and development, with revenue generated through the commercialization of its proprietary drugs, partnerships, and licensing agreements. Tosk operates in the biopharmaceutical sector, leveraging cutting-edge research and development to address unmet medical needs in oncology.
Source: Dealroom company dataAt a glance
- Founded
- 1998
- Headquarters
- Mountain View, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
National Cancer Institute (NCI)
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Tosk on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Tosk on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.